[PET and SPECT in epilepsy]
- PMID: 24565567
- DOI: 10.1016/j.remn.2014.01.001
[PET and SPECT in epilepsy]
Abstract
Epilepsy is one of the most frequent chronic neurological disorders, affecting 1-2% of the population. Patients with complex partial drug resistant episodes may benefit from a surgical treatment consisting in the excision of the epileptogenic area. Localization of the epileptogenic area was classically performed with video-EEG and magnetic resonance (MR). Recently, functional neuroimaging studies of Nuclear Medicine, positron emission tomography (PET) and single photon emission tomography (SPECT) have demonstrated their utility in the localization of the epileptogenic area prior to surgery. Ictal SPECT with brain perfusion tracers show an increase in blood flow in the initial ictal focus, while PET with (18)FDG demonstrates a decrease of glucose metabolism in the interictal functional deficit zone. In this review, the basic principles and methodological characteristics of the SPECT and PET in epilepsy are described. The ictal SPECT injection mechanism, different patterns of perfusion based on the time of ictal, postictal or interictal injection are detailed and the different diagnostic sensitivities of each one of these SPECT are reviewed. Different methods of analysis of the images with substraction and fusion systems with the MR are described. Similarly, the injection methodology, quantification and evaluation of the images of the PET in epilepsy are described. Finally, the main clinical indications of SPECT and PET in temporal and extratemporal epilepsy are detailed.
Keywords: Epilepsia; Epilepsy; Ictal SPECT; Interictal SPECT; Positron emission tomography; SISCOM; SPECT ictal; SPECT interictal; Tomografía por emisión de positrones.
Copyright © 2014 Elsevier España, S.L. and SEMNIM. All rights reserved.
Similar articles
-
Perfusion SPECT, SISCOM and PET (18)F-FDG in the assessment of drug- refractory epilepsy patients candidates for epilepsy surgery.Rev Esp Med Nucl Imagen Mol. 2015 Nov-Dec;34(6):350-7. doi: 10.1016/j.remn.2015.05.002. Epub 2015 Jun 26. Rev Esp Med Nucl Imagen Mol. 2015. PMID: 26118354 English, Spanish.
-
Neuronuclear assessment of patients with epilepsy.Semin Nucl Med. 2008 Jul;38(4):227-39. doi: 10.1053/j.semnuclmed.2008.02.004. Semin Nucl Med. 2008. PMID: 18514079 Review.
-
Clinical Role of Subtraction Ictal SPECT Coregistered to MR Imaging and (18)F-FDG PET in Pediatric Epilepsy.J Nucl Med. 2014 Jul;55(7):1099-105. doi: 10.2967/jnumed.113.136432. Epub 2014 May 5. J Nucl Med. 2014. PMID: 24799620
-
Functional neuroimaging in epilepsy: FDG PET and ictal SPECT.J Korean Med Sci. 2001 Dec;16(6):689-96. doi: 10.3346/jkms.2001.16.6.689. J Korean Med Sci. 2001. PMID: 11748346 Free PMC article. Review.
-
Utility of gray-matter segmentation of ictal-Interictal perfusion SPECT and interictal 18F-FDG-PET in medically refractory epilepsy.Epilepsy Res. 2017 Feb;130:93-100. doi: 10.1016/j.eplepsyres.2017.01.009. Epub 2017 Jan 30. Epilepsy Res. 2017. PMID: 28171851
Cited by
-
Clinical Value of Hybrid TOF-PET/MR Imaging-Based Multiparametric Imaging in Localizing Seizure Focus in Patients with MRI-Negative Temporal Lobe Epilepsy.AJNR Am J Neuroradiol. 2018 Oct;39(10):1791-1798. doi: 10.3174/ajnr.A5814. Epub 2018 Sep 20. AJNR Am J Neuroradiol. 2018. PMID: 30237304 Free PMC article.
-
Application value of molecular imaging technology in epilepsy.Ibrain. 2021 Sep 28;7(3):200-210. doi: 10.1002/j.2769-2795.2021.tb00084.x. eCollection 2021 Sep. Ibrain. 2021. PMID: 37786793 Free PMC article. Review.
-
Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases.Neurotherapeutics. 2023 Apr;20(3):767-778. doi: 10.1007/s13311-023-01355-7. Epub 2023 Mar 8. Neurotherapeutics. 2023. PMID: 36884195 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical